Atossa Therapeutics Inc (ATOS) Stock: Navigating a Year of Volatility

CSCO Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Atossa Therapeutics Inc’s current trading price is -56.05% away from its 52-week high, while its distance from the 52-week low is 43.96%. The stock’s price range during this period has varied between $0.55 and $1.81. The company, active in the Healthcare sector, saw a trading volume of around 0.73 million for the day, considerably higher average daily volume of 0.63 million observed over the last three months.

Atossa Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.81 on 05/08/24, while the lowest price during the same period was $0.55 on 04/07/25.

How Financial Performance Impacts Market Capitalization

Atossa Therapeutics Inc (ATOS) has experienced a quarterly decline of -9.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 102.76M and boasts a workforce of 15 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8365, with a change in price of -0.4745. Similarly, Atossa Therapeutics Inc recorded 735,201 in trading volume during the last 100 days, posting a change of -37.36%.

How ATOS’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ATOS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATOS Stock Stochastic Average

As of today, the raw stochastic average of Atossa Therapeutics Inc over the last 50 days is at 73.07%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 94.22%. Further, the company’s Stochastic %K and %D values for the last 20 days were 92.07% and 90.23%, respectively.

ATOS Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -15.74%.However, over the last six months, we can see a stronger performance of -43.58%. Over the last 30 days, the price of ATOS has fallen by 14.26%. And in the last five days, it has surged by 19.91%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.